Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07219589 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Apr 2026 to Mar 2027v5 Show 6 more changesShow less
    • Primary endpoint(s) modified
    • Enrollment increased: 40 → 90 participants
    • Eligibility criteria expanded, about 115 words
    • Secondary endpoints: details revised at 3 of 3 entries
    • Study description expanded, about 140 words
    • Study title expanded, about 3 words
  2. Site contact updated
    • Study title expanded, about 2 words
    v4
  3. Start date changed from estimate of Nov 18, 2025 to Nov 6, 2025v3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Primary endpoint revised
    • Primary and study completion dates: May 2026 to Apr 2026
    • Start date: Dec 2025 to Nov 18, 2025
    • Secondary endpoints: 1 to 3
    • Site details revised
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HM17321 after single and multiple ascending doses in healthy and obese participants.
Trial Details
NCT Number NCT07219589
Lead Sponsor Hanmi Pharmaceutical Company Limited
Conditions
(from sponsor)		 Obesity, Obese
Related terms Obesity
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov